Catch up on the highlights now
Catch up on the highlights now
North American Cystic Fibrosis Conference Logo
That’s a wrap on this year’s North American Cystic Fibrosis Conference! More than 5,000 researchers, clinicians, and community members joined us online for important discussions on the latest in cystic fibrosis research, care, and drug development.

Three adults living with CF share their top learnings from this year’s plenary sessions.

Plenary 1: Laying the Foundation for the Path to a Cure: The Fundamentals of Genetic-Based Therapies

For Preston Hinkle, genetic-based therapies for CF seemed like a theoretical idea. Following plenary one of NACFC, he shares his four takeaways to help tackle a genetic-based therapy for CF and move forward on our path to a cure.
Read Preston's blog »
Watch Plenary 1 on Facebook Live »

Plenary 2: Defining the New CF in the Era of Highly Effective Modulators

A year ago, the CF community celebrated the approval of Trikafta, a highly effective CFTR modulator for individuals with at least one copy of the F508del mutation. Mara Cray shares her thoughts on a “new cystic fibrosis” after plenary two of NACFC and her personal experience on CFTR modulators.
Read Mara's blog »
Watch Plenary 2 on Facebook Live »

Plenary 3: Advancing the GI Frontier for People with CF

Gastrointestinal issues are common in people with CF but have not always been prioritized in research and care. Cade Hovater, who has dealt with GI issues all his life, shares his top takeaways from plenary three of NACFC, including what’s being done to train more GI specialists in CF care.
Read Cade's blog »
Watch Plenary 3 on Facebook Live »
Facebook
Twitter
Instagram
Opt-out of this mailing list
Opt-out of all CFF emails